<!DOCTYPE html>
<html lang="en">
<head>


	
  
  <meta charset="utf-8">


	
  
  <meta http-equiv="X-UA-Compatible" content="IE=edge">


	
  
  <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">


	 
  
  <title></title>
  <style>
body { 
	background-image:url();
	background-repeat: repeat-x;
	background-color:#e5dfc6;
	}
body, .cfsbdyfnt {
	font-family: 'Rasa', serif;
	font-size: 18px;
}
h1, h2, h3, h4, h5, h5, .cfsttlfnt {
	font-family: 'EB Garamond', serif;
}

.panel-title { font-family: 'Rasa', serif; }

  </style>

 
  
  <style id="sitestyles">
	@import url( solid rgba(90,98,28,.6);box-shadow:none!important;border-radius:0}.btn-default{color:#fff!important;border-color:#506e55!important;background-color:#506e55!important}.btn-default:hover{color:#506e55!important;background-color:#fff!important;border-color:#fff!important}.btn-primary{color:#fff!important;border-color:#5a621c!important;background-color:#5a621c!important}.btn-primary:hover{color:#5a621c!important;background-color:#fff!important;border-color:#fff!important}.btn-info{color:#fff!important;border-color:#073d26!important;background-color:#073d26!important}.btn-info:hover{color:#073d26!important;background-color:#fff!important;border-color:#fff!important}.btn-success{color:#fff!important;border-color:#073d26!important;background-color:#073d26!important}.btn-success:hover{color:#073d26!important;background-color:#fff!important;border-color:#fff!important}.btn-social{color:#fff!important;background-color:#506e55}.btn-social:hover{background-color:#fff;color:#506e55!important}#block-outhdr{margin-left:-1vw!important;margin-right:-1vw!important}#block-outhdr .upperbanner{background-color:#fff!important}#block-outhdr .pinned-tel{display:none}#block-outhdr p,#block-outhdr a,#block-outhdr h3{color:#5a621c}#block-outhdr a{color:#506e55}.banner-box{background:#e6e1d4}.js-clingify-locked .logobanner{display:none}.js-clingify-locked .pinned-tel{display:initial!important}{border-top:2px dotted #bbb;background-image:none}.obitname{font-weight:700;font-size:90%}.horizobits{font-size:90%}.obit-hdr-v2{max-width:1170px!important;float:none!important;margin:auto!important}.form-control{max-width:1096px;margin-left:auto;margin-right:auto}.btn-tree{display:none}.glyphicon-chevron-right,.glyphicon-chevron-left{color:#5a621c}.glyphicon-chevron-right:hover,.glyphicon-chevron-left:hover{color:rgba(90,98,28,.5)}.container-body{color:#000!important}a{text-decoration:none}a:hover{text-decoration:none}a .blocks{background:#073d26;color:#fff;padding:8px;height:40px}a .blocks:hover{background:rgba(7,61,38,.4)}.testimonials-box .well{border:0;box-shadow:none;background:rgba(255,255,255,0)}.featuredservices-box .hbutton{background-color:rgba(0,0,0,.3);color:#fff}.featuredservices-box .hbutton:hover{background-color:rgba(255,255,255,.75);color:#000!important;text-shadow:0 0 0 #000}.blackbg{background:#506e55}[data-typeid="locationmap"]{background:#14af6d}[data-typeid="locationmap"] iframe{border:none;filter:grayscale(1) sepia(2%) opacity(.90);transition:all 2s ease}[data-typeid="locationmap"] iframe:hover{filter:unset}[data-typeid="multimap"]{background:transparent}[data-typeid="multimap"] .multimap{border:0 solid #ccc;background:#0f8251}[data-typeid="multimap"] .multimap .leaflet-tile-pane{-webkit-filter:opacity(.85) grayscale(60%) brightness(1.1);-moz-filter:opacity(.85) grayscale(60%) brightness(1.1);filter:opacity(.85) grayscale(60%) brightness(1.1);transition:all .5s ease}[data-typeid="multimap"] .multimap:hover .leaflet-tile-pane{-webkit-filter:opacity(1) grayscale(0%) brightness();-moz-filter:opacity(1) grayscale(0%) brightness();filter:opacity(1) grayscale(0%) brightness()}[data-typeid="multimap"] .multimap .leaflet-marker-pane .leaflet-marker-icon:hover{filter:brightness()}[data-typeid="multimap"] .multimap .leaflet-popup{border:2px solid mediumblue}[data-typeid="multimap"] .multimap .leaflet-popup h4{color:mediumblue;font-weight:700;font-size:;text-align:center}[data-typeid="multimap"] .multimap .leaflet-popup .leaflet-popup-content-wrapper{background:linear-gradient(rgba(255,255,255,.7),white);border-radius:0;box-shadow:none}[data-typeid="multimap"] .multimap .leaflet-popup .leaflet-popup-tip{background:rgba(255,255,255,.8);border-bottom:2px solid mediumblue;border-right:2px solid mediumblue;display:none}[data-typeid="multimap"] .multimap button{background:#888;border-radius:0}[data-typeid="multimap"] .multimap button:hover{background:mediumblue}[data-typeid="multimap"] .multimap-location{border:none;border-top:4px solid #ccc;border-radius:0;background:#eee;margin-top:5px}[data-typeid="multimap"] .multimap-location h4{color:#000;font-weight:700}[data-typeid="multimap"] .multimap-location:hover{background:radial-gradient(#fff,#eee);border-top:4px solid #888}[data-typeid="multimap"] .{background:rgba(238,238,238,.5);border-top:4px solid #c00}[data-typeid="multimap"] .multimap-location button{color:white;background:#888;border-radius:0;margin-bottom:10px}[data-typeid="multimap"] .multimap-location button:hover{background:mediumblue}#block-inftr{background-color:#073d26!important;padding-bottom:15px;border-top:4px solid #5a621c}#block-inftr a,#block-inftr p,#block-inftr .addressitem,#block-inftr label,#block-inftr h3{color:#fff}#inftr{background-color:transparent!important}.site-credit .credit-text,.site-credit .credit-text a{background-color:transparent;color:#333}.site-credit{padding-bottom:0px!important}.panel-title{background:transparent;color:#fff}.panel-heading{background:#506e55!important}.panel{border:1px solid #506e55!important;background:#fff}.panel a{color:#506e55}.panel .selected{background:rgba(80,110,85,.2);border-radius:0;margin-left:-30px;margin-right:-30px;padding-left:35px!important}.section-listing{padding:5px}.panel-default>.panel-body{background:rgba(80,110,85,.05)!important}.cfsacdn .panel-title{background:transparent}.cfsacdn .panel-title a{color:#fff!important}.cfsacdn .panel-heading{background:#5a621c!important}.cfsacdn .panel{border-color:#5a621c!important}.cfsacdn .panel font{color:#333}#innersite{padding-top:0}.max1170{max-width:1170px!important;float:none!important;margin:auto!important}body{max-width:100%;overflow-x:hidden}.small-text{font-size:80%!important}#strip{background-color:transparent!important}.lead .cfshdg h1,.lead .cfshdg h2,.lead .cfshdg h3,.lead .cfshdg h4,[data-typeid="pagetitle"] h1,[data-typeid="pagetitle"] h2,[data-typeid="pagetitle"] h3,[data-typeid="pagetitle"] h4{font-family:'Allura',cursive}.lead .cfshdg h1 small,.lead .cfshdg h2 small,.lead .cfshdg h3 small,.lead .cfshdg h4 small,[data-typeid="pagetitle"] h1 small,[data-typeid="pagetitle"] h2 small,[data-typeid="pagetitle"] h3 small,[data-typeid="pagetitle"] h4 small{font-family:sans-serif!important;font-size:.55em}.lead .cfshdg h1,[data-typeid="pagetitle"] h1{font-size:}.lead .cfshdg h2,[data-typeid="pagetitle"] h2{font-size:}.lead .cfshdg h3,[data-typeid="pagetitle"] h3{font-size:}.lead .cfshdg h4,[data-typeid="pagetitle"] h4{font-size:}[data-typeid="pagetitle"]{color:#0c6b43}.obitlist-title a{color:#000}{color:#333}{color:#000}{color:#000}#popout-add h4,#popout-settings h4{color:#fff}.btn-danger{color:#fff!important;border-color:#5cb85c!important;background-color:#5cb85c!important}.btn-danger:hover{color:#5cb85c!important;background-color:#fff!important;border-color:#fff!important}div#struct5099239544977{display:none}div#smart5054996858510{margin-top:820px}div#smart5054996858510 .btn-default{color:#073d26!important;font-size:16px;text-transform:uppercase;border-color:#5a632e!important;background-color:#fbfbfa!important;padding:10px 20px;box-shadow:1px 1px 2px #888}div#smart5054996858510 .btn-default:hover{color:#fff!important;font-size:16px;text-transform:uppercase;border-color:#5a632e!important;background-color:#5a621c!important;padding:10px 20px;box-shadow:1px 1px 2px #888}div#smart2594764877558{margin-top:520px}div#smart2594764877558 .btn-default{color:#073d26!important;font-size:13px;text-transform:uppercase;border-color:#5a632e!important;background-color:#fbfbfa!important;padding:10px 20px;box-shadow:1px 1px 2px #888}div#smart2594764877558 .btn-default:hover{color:#fff!important;font-size:13px;text-transform:uppercase;border-color:#5a632e!important;background-color:#5a621c!important;padding:10px 20px;box-shadow:1px 1px 2px #888}div#smart2679040218045{margin-top:250px}div#smart2679040218045 .btn-default{color:#073d26!important;font-size:10px;text-transform:uppercase;border-color:#5a632e!important;background-color:#fbfbfa!important;box-shadow:1px 1px 2px #888}div#smart2679040218045 .btn-default:hover{color:#fff!important;font-size:10px;text-transform:uppercase;border-color:#5a632e!important;background-color:#5a621c!important;box-shadow:1px 1px 2px #888}#stdmenustrip{margin-top:0px!important}.cfshznav a{color:#fff!important}.cfshznav .open a{color:#fff!important}.cfshznav a:hover{color:#fff!important}.cfshznav .dropdown-menu li a{color:#5a621c!important}.cfshznav .dropdown-menu a:hover{color:#fff!important}.navbar{background-color:#073d26;border:0;box-shadow:0 4px 10px rgba(0,0,0,.5);margin-left:-1vw;margin-right:-1vw}.navbox{background-color:#073d26!important}.navbar-nav .open {background-color:#5a621c!important}.navbox a:hover{background-color:#5a621c!important}.navbar .dropdown-menu li a{background:#fff!important}.navbar .dropdown-menu li a:hover{background:#5a621c!important}
	</style>
  
  <style>
  .ratio{
    position: relative;
    width: 100%;
  }
.ratio>* {
    position: absolute;
    top: 0;
    left: 0;
    width: 100%;
    height: 100%;
}
  .ratio::before {
      display: block;
      padding-top: %;
      content: "";
  }
  div[data-typeid="calendar"] .fc button{
    padding: 0 5px;
  }
  @media(min-width: 768px){
    .logobanner .row{
      display: flex;
      align-items: center;
    }
  }
  </style>
  
  <style> #smart3201098991086-1 { color: @light !important; background-color: @accent } #smart3201098991086-1:hover { color: @accent !important; background-color: @light } #smart3201098991086-2 { color: @light !important; background-color: @accent } #smart3201098991086-2:hover { color: @accent !important; background-color: @light } #smart3201098991086-3 { color: @light !important; background-color: @accent } #smart3201098991086-3:hover { color: @accent !important; background-color: @light } </style>
</head>


<body class="cs1-14">



<!-- Google Tag Manager (noscript) -->
 




<div id="pubdyncnt"></div>





<div id="site" class="container-fluid">


		
<div id="innersite" class="row">

			
<div id="block-outhdr" class="container-header dropzone">
				
<div class="row stockrow">
					
<div id="outhdr" class="col-xs-12 column zone">
<div class="inplace pad-left pad-right" data-type="smart" data-typeid="code" data-desc="Embedded Code" data-exec="1" data-rtag="code" id="smart4231816111478" data-itemlabel="">
<div class="embeddedcode">
	<!--Be sure to apply corresponding IDs and Class, if applicable, in Inspect. Remove // if disabled styles are needed. -->


</div>


</div>

<div class="inplace upperbanner pinned-item" data-type="struct" data-typeid="FullCol" data-desc="Full Col" data-exec="1" id="struct3788564611071" data-o-bgid="" data-o-bgname="" data-o-src="">
<div class="row">
<div class="col-sm-12 column ui-sortable">
<div class="inplace pad-bottom pad-top max1170 logobanner" data-type="struct" data-typeid="TwoCols" data-desc="Two Cols" data-exec="1" id="struct2034876210511" data-o-bgid="" data-o-bgname="" data-o-src="" data-itemlabel="" style="position: relative; left: 0px; top: 0px;">
<div class="row">
<p>Zomedica stocktwits news. yahoo.  October 01, 2021 06:01 ET </p>

<div class="col-md-6 col-sm-5 column ui-sortable">
<div class="inplace pad-top pad-bottom pull-left hidden-xs" data-type="image" data-typeid="site" data-desc="Site Image" id="image38037808484" style="position: relative; z-index: 2; left: 0px; top: 0px; max-width: 49%;" data-maxwid="49%" data-itemlabel=""></div>

<div class="inplace hidden-md hidden-lg hidden-sm pad-top" data-type="image" data-typeid="site" data-desc="Site Image" id="image3493169348526" style="" data-itemlabel=""></div>

</div>

<div class="col-md-6 col-sm-7 column ui-sortable">
<div class="inplace pad-left pad-right transparent txtbg5 hidden-xs lead" data-type="generic" data-typeid="Heading" data-desc="Heading" id="generic5908982442615" style="position: relative; left: 0px; top: 0px;" data-itemlabel=""><grammarly-extension data-grammarly-shadow-root="true" style="position: absolute; top: 0px; left: 0px;" class="cGcvT"></grammarly-extension><grammarly-extension data-grammarly-shadow-root="true" style="position: absolute; top: 0px; left: 0px;" class="cGcvT"></grammarly-extension>
<div class="cfshdg text-right" contenteditable="false" spellcheck="false">
<h3 style="text-align: center;"><span style="text-decoration: underline;">Zomedica stocktwits news. yahoo.  October 01, 2021 06:01 ET | Source: Zomedica Corp.  P/E Ratio.  Watch list After Hours Last Updated: Aug 22, 2023 6:18 p.  … 52 Week Low Date 12/27/22.  ANN ARBOR, MI / ACCESSWIRE / January 17, 2023 / Zomedica Corp.  ZOM stock is worth between $2.  (NYSE American:ZOM) (&quot;Zomedica&quot; or the &quot;Company&quot;), a veterinary health company offering diagnostic and therapeutic products for companion animals, will host a conference call and Mar 17, 2023&ensp;&#0183;&ensp;/ Zomedica Corp. 3 million shares; it showed minuscule peak to trough movement on the day. 25%) (As of 08/22/2023 ET) Compare Today's Range $0.  Our team of animal health Mar 16, 2023&ensp;&#0183;&ensp;Zomedica Corp.  5.  As a highly shorted stock, Zomedica is a company that is in the crosshairs of short-squeeze speculators.  -0.  Oct 1, 2021&ensp;&#0183;&ensp;Zomedica Corp.  is acting as the sole book-running manager for the offering.  Mar 30, 2021&ensp;&#0183;&ensp;Zomedica Pharmaceuticals (ZOM-4. 1492.  Three months earlier, in the first quarter, that line item totaled just $3.  Dividend -.  August 16-19, 2023. 205: Enterprise Value/EBITDA-4.  Its TRUFORMA biosensor platform is designed to assist … May 10, 2022&ensp;&#0183;&ensp;About Zomedica. 18 $0.  Zomedica recorded net loss and comprehensive loss for the three months ended March 31, 2021 of approximately $4.  Company Videos.  Investors. 0 million and incurred a direct charge to Aug 26, 2021&ensp;&#0183;&ensp;Zomedica has been investing into its sales force, and for the second quarter ended June 30, its SG&amp;A was $5.  Zomedica revealed that there was a Jan 13, 2021&ensp;&#0183;&ensp;Zomedica has announced that they will begin commercialization of TRUFORMA on March 30, 2021, and will continue the development of ZM-020 and ZM-017 diagnostic platforms (to diagnose … Mar 15, 2023&ensp;&#0183;&ensp;1-800-RED-CHIP (733-2447) Or 407-491-4498.  Careers Contact. 00 in the next twelve months. 18 -0.  ZOM NEWS - IBD PARTNERS; IBD.  operates as a veterinary health company, which engages in the discovery, development, and commercialization of pharmaceuticals for … ZOM Overview Stock Screener Earnings Calendar Sectors | ZOM U. 29M Volume (M) 1,544.  This page (NASDAQ:IDEX) was last updated on 8/20/2023 by MarketBeat.  N/A.  S&amp;P 500 0.  EDT … Zomedica Corp (NYSE American:ZOM) 0.  Dividend Yield.  (NYSE American:ZOM) (&quot;Zomedica&quot; or the &quot;Company&quot;), a veterinary health company offering diagnostic and therapeutic Jan 19, 2023&ensp;&#0183;&ensp;Zomedica Corp.  “As part of the executive team who helped transform Zomedica, Ms.  Trending now.  The treatment can be modified to treat … Jul 20, 2021&ensp;&#0183;&ensp;The buyers managed to lift the ZOM stock price up to $1.  SOURCE: Zomedica Corp.  Stocktwits is the largest social network for finance.  On Feb. Latest News.  Beta 0.  (ZOM) on Wednesday, March 15, 2023 as an 8K 2.  Using various sizes of trodes and energy settings on the device, PulseVet allows for customized penetration depths up to 110 mm, deeper than any other device.  (ZOM) stock at Seeking Alpha.  2 days ago&ensp;&#0183;&ensp;Checkout Zomedica Corp (ZOM) earnings results, EPS expectations and actual EPS values for both quarterly and annual periods. 19 50-Day Range N/A 52-Week … Zomedica Kyle Follow Strategy: Joined 2/2021 0 Following 16 Followers 0 Posts 0 Liked 3 Watchlist Portfolio 3rd Party Ad. 382M.  What is the 52-week low for Zomedica Corp? 52 week low is the lowest price of a stock in the past 52 … Aug 11, 2023&ensp;&#0183;&ensp;Get all financial information for Zomedica Corp (ZOM) including Market Capitalization, PE Ratio, EBITDA, EPS, previous close and open price, 52 week high &amp; … ZOM Stock Price - Zomedica Corp. 4% this week, according to data from S&amp;P Global Market Intelligence. 0-$6.  (NYSE American:ZOM) (&quot;Zomedica&quot; or the &quot;Company&quot;), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, today reported Jun 15, 2022&ensp;&#0183;&ensp;About Zomedica. 43%) rose 72. 7 million May 12, 2023&ensp;&#0183;&ensp;Zomedica Corp.  Cotter’s accomplishments on behalf of the … ANN ARBOR, Mich. 5 Million in Liquidity. 97 million loss for the fourth Zomedica (NYSE American:ZOM) is a veterinary health company focused on meeting the needs of clinical veterinarians in ways that promote both patient and practice health.  Zomedica stock predictions for November 2023.  Earnings. 5%. 24% to close the trading session at $2.  Run for the Million.  … Zomedica (ZOM) Message Board - Company Name: Zomedica , Stock Symbol: ZOM, Industry: Medical - Healthcare - Total Posts: 3158 - Last Post: 08/17/2023 10:20:29 AM - company/specific stock board Subscribe to our daily news briefing, partner offers and other newsletters catered to investors like you! Home; Boards Mar 17, 2023&ensp;&#0183;&ensp;Mr. 9 million or $0.  The high share count can be dealt with later.  Wainwright &amp; Co.  Latest News.  Apr 28, 2021&ensp;&#0183;&ensp;In the fourth quarter, Zomedica posted a loss of 5 cents a share. 06M.  (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care Aug 18, 2023&ensp;&#0183;&ensp;Ideanomics' mailing address is 55 BROADWAY 19TH FLOOR, NEW YORK NY, 10006.  30, 2021 1173 Comments. 6 billion by 2028, and the companion animal diagnostics market is forecasted to reach $12.  Join … 1 day ago&ensp;&#0183;&ensp;Zomedica Corp 52 week high is $0. ideanomics.  Perhaps this can Feb 9, 2023&ensp;&#0183;&ensp;Preliminary (unaudited) Fourth Quarter and Full Year 2022 Results: Revenue for the fourth quarter of 2022 is expected to be approximately $6. , formerly known as Zomedica Jan 10, 2023&ensp;&#0183;&ensp;Zomedica opened that morning at $0.  Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement ZOM Stock Price - Zomedica Corp. 335 as of August 22, 2023.  (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating Jan 12, 2021&ensp;&#0183;&ensp;Shares of Zomedica Pharmaceuticals (ZOM-3.  Join Stocktwits for free stock discussions, prices, and market sentiment with millions of investors and traders.  Log In.  The largest community for investors and traders Aug 19, 2023&ensp;&#0183;&ensp;Complete Zomedica Corp.  ANN ARBOR, MI / ACCESSWIRE / August 23, 2022 / Zomedica Corp.  On March 15, Zomedica commenced commercialization of Truforma.  EST, the veterinary health company's stock price is up more than 40%.  (NYSE American:ZOM) ('Zomedica' or the 'Company'), today announced it has exercised its option to move forward with the acquisition of Structured Monitoring Products, Inc. 98 about a year later, ZOM stock rolled over and all but played dead for its shareholders.  (NYSE American: ZOM) (“Zomedica” or the Apr 1, 2022&ensp;&#0183;&ensp;Shares of Zomedica have fallen a staggering 80% over the past year.  The good news is the message boards may not have been entirely wrong in hyping ZOM stock.  10: MT Zomedica Seeks M&amp;A Opportunities Aug. 94.  During the last trading day the stock fluctuated 3. com Staff.  1 day ago&ensp;&#0183;&ensp;Stocktwits provides real-time stock, crypto &amp; international market data to keep you up-to-date.  In fact, an investment of $10,000 in its shares last March 20 hours ago&ensp;&#0183;&ensp;A Complete Shanghai Composite Index overview by Barron's. 0 million in the Fourth Quarter 2021, an increase of 66% over Aug 18, 2023&ensp;&#0183;&ensp;2 brokerages have issued 12-month price targets for Corbus Pharmaceuticals' shares.  Betting on this meme stock in 2021 would have turned a $10,000 investment into less than $2,000 today.  YTD % Change 22.  The stock hit a delisting-worthy 6 Jul 18, 2022&ensp;&#0183;&ensp;Zomedica Corp.  No News Available.  Its initial runup in June of 2018 took it to nearly $3. 43%) were soaring 14.  The big jump came after the veterinary health company provided a sneak peek at its 2021 fourth-quarter and .  Sentiment.  May 19, 2021&ensp;&#0183;&ensp;At a price of around 83 cents, Zomedica ’s bullish animal spirits have been declawed by roughly 76%.  Corporate Overview.  ANN ARBOR, MI / ACCESSWIRE / August 15, 2022 / Zomedica Corp.  For growth investors, this is Aug 16, 2023&ensp;&#0183;&ensp;Get Zomedica Corp (zom) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments Aug 11, 2023&ensp;&#0183;&ensp;Get all financial information for Zomedica Corp (ZOM) including Market Capitalization, PE Ratio, EBITDA, EPS, previous close and open price, 52 week high &amp; 52 week low, Beta and much more News.  Not an … Oct 1, 2021&ensp;&#0183;&ensp;Zomedica Acquires PulseVet.  Dividend Yield -. 43% on the last trading day (Monday, 21st Aug 2023), rising from $0.  Corporate Overview Financial Reports Filings News Releases Investor Alerts.  (NYSE American:ZOM) (' Zomedica ' or the 'Company'), a veterinary health company offering diagnostic and therapeutic products for companion animals, today announced a strategic restructuring of its existing development and commercialization agreements with Qorvo Biotechnologies (' Qorvo ') for the Company's … Jun 9, 2023&ensp;&#0183;&ensp;Zomedica Corp. 03%) 4:00 PM 08/17/23. 28: … 2 days ago&ensp;&#0183;&ensp;Institutional Ownership and Shareholders. 00.  ANN ARBOR, MI / ACCESSWIRE / August 10, 2023 / Zomedica Corp.  This is up from a baseline of $1.  In the first quarter, the company's sales totaled $14,124.  May 11, 2023.  Based in Ann Arbor, Michigan, Zomedica (NYSE American: ZOM) is a veterinary health company creating products for dogs and cats by focusing on the unmet needs of clinical veterinarians.  (NYSE American:ZOM) (&quot;Zomedica&quot; or the &quot;Company&quot;), a veterinary health company offering … Stocktwits is the largest social network for finance.  SA News Sat, Jan.  Aug 22, 2023&ensp;&#0183;&ensp;Latest Zomedica Corp (ZOM:ASQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.  Period. 7 billion in 2019, a near-double-digit CAGR.  Sidoti Micro-cap Virtual Conference. 19 0.  (SMP), it will … May 17, 2021&ensp;&#0183;&ensp;ANN ARBOR, Mich.  Donato succeeds Ann Marie Cotter, who served as Zomedica’s Vice President of Finance from August 2018 until October 2020, and subsequently as Chief Financial Officer.  Find top news headlines, discover your next trade idea, share &amp; gain insights from traders and investors from around the world, build a watchlist, buy US stocks, &amp; create and manage your portfolio. 00 to $3.  Delayed Data.  Nov 14, 2022&ensp;&#0183;&ensp;Zomedica Corp.  PulseVet revenue grew to $4.  stock information by Barron's.  (NYSE American: ZOM) (“Zomedica” or the “Company Aug 17, 2023&ensp;&#0183;&ensp;Get the latest news and real-time alerts from Zomedica Corp.  Patience will pay off.  30, 2021, Zomedica reported Aug 19, 2023&ensp;&#0183;&ensp;Zomedica stock price predictions for October 2023.  finance.  Market Cap 196.  ANN ARBOR, Mich.  18, 2023 6:29 AM ET Zomedica Corp.  Moreover, during the nine months that ended on Sept. 0015 (0. 1473.  However, its $17 million loss for the year represented an 8% improvement, and its loss of $1.  Eastern Time (ET). 2480 on moderate volume of ~9. 5 Million; Strong 70% Gross Margin &amp; $147.  This is still better than the 19 cents a share, or $19. , May 17, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp.  (NYSE American:ZOM) (&quot;Zomedica&quot; or the &quot;Company&quot;), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, today reported Aug 18, 2023&ensp;&#0183;&ensp;The Zomedica stock price gained 2.  ZOM@redchip. 03%.  Headline.  Cancel. 15 hours ago&ensp;&#0183;&ensp;Track Zomedica Corp (ZOM) Stock Price, Quote, latest community messages, chart, news and other stock related information.  So wether they keep growing organically or get bought out, it’s win win going forward.  Not an offer or recommendation by Stocktwits. 05 per share, compared to a loss of Jun 9, 2023&ensp;&#0183;&ensp;TRUVIEW's digital imaging and telepathology component is an easy-to-use interface providing veterinarians with multiple diagnostic options, including reading the slide directly on the microscope, reviewing the slide digitally from a remote computer through the Company's myZomedica&#174; web portal, or sending the image to a Zomedica pathologist … Apr 28, 2021&ensp;&#0183;&ensp;Why the ZOM Stock Rally Faded. 2 million, an increase of 46-51% compared to the Jul 18, 2022&ensp;&#0183;&ensp;ANN ARBOR, MI / ACCESSWIRE / July 18, 2022 / Zomedica Corp. 32% to close the trading session at $1.  NASDAQ 0.  On average, they anticipate the company's stock price to reach $3.  Thus The latest messages and market ideas from Kyle (@Zomedica) on Stocktwits. 186. 14%) has been one of the most intriguing (and best-performing) healthcare penny stocks in the past year.  Largest shareholders include Vanguard Group Inc, VTSMX - Vanguard Total Stock Market Index … Oct 1, 2021&ensp;&#0183;&ensp;Zomedica Acquires PulseVet.  As of 11:33 a.  Zomedica reported a net loss for the three and six months ended June 30, 2021 of approximately $4.  The company can be reached via phone at (212) 206-1216 or via email at ir@ideanomics.  finanznachrichten.  Top Stocks to Buy in 2023 Stock Market News Retirement Getting Started.  Upcoming Events.  (NYSE American:ZOM) (&quot;Zomedica&quot; or the &quot;Company&quot;, a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, reported Feb 28, 2022&ensp;&#0183;&ensp;Shares of Zomedica ( ZOM -3.  Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 May 12, 2021&ensp;&#0183;&ensp;Summary First Quarter 2021 Results.  Our mission is to advance the effectiveness and financial well-being of veterinary practitioners by delivering professionally beneficial products and Mar 19, 2021&ensp;&#0183;&ensp;Thus far, the stock has had mixed results leading up to Truforma’s release, and on Tuesday Zomedica dropped by 9.  As shown by its price Feb 8, 2023&ensp;&#0183;&ensp;February 8, 2023 - 4:15 pm.  STOCK/COMPANY DATA FOR ZOM . 5 million.  This suggests that the stock has a possible downside of 54.  Aug 11, 2021&ensp;&#0183;&ensp;Summary Second Quarter 2021 Results.  (ZOM), ZOM:CA By: Ravikash, SA News Editor 2 Comments.  As of Aug 18.  (NYSE:NYSE:ZOM) Q4 2022 Earnings Conference Call March 15, 2023 4:30 PM ETCompany ParticipantsLarry Heaton - Chief Executive OfficerAnn Cotter - Chief Financial OfficerPaul ZOM closed down 1.  Based in Ann Arbor, Michigan, Zomedica (NYSE American: ZOM) is a veterinary health company creating products for companion animals by focusing on the unmet needs of clinical Jan 9, 2022&ensp;&#0183;&ensp;Subscribe to our daily news briefing, partner offers and other newsletters catered to investors like you! Home; Boards US Listed Medical - Healthcare; Zomedica (ZOM) It’s been approved by shareholders and Zomedica so let’s see what happens. 9%.  10 Day Average Volume 3.  Price at the end 0.  Averaged Zomedica stock price for month 0.  Feb 9, 2021&ensp;&#0183;&ensp;H.  By Will Ashworth, InvestorPlace Contributor Oct 21, 2021, 3:41 pm EDT.  (NYSE American:ZOM) (&quot;Zomedica&quot; or the &quot;Company&quot;), a leading innovator in veterinary medicine offering diagnostic and therapeutic products for companion animals, announced today the Oct 12, 2021&ensp;&#0183;&ensp;Zomedica is still a small company, but it’s developing well. 4 Million in Liquidity.  August 16-17, 2023.  Minimum 15 minutes delayed.  Their CRBP share price forecasts range from $3.  #ZOMEDICA.  (NYSE:NYSE:ZOM) Q1 2023 Results Conference Call May 11, 2023 4:30 PM ETCompany ParticipantsLarry Heaton - CEOPeter Donato - CFOConference Call ParticipantsJason Kolbert - Jan 7, 2022&ensp;&#0183;&ensp;Yet there was no such indication: Zomedica actually generated just $22,514 of sales in three months’ time.  (NYSE American:ZOM) (&quot;Zomedica&quot; or the &quot;Company&quot;), a veterinary health company offering diagnostic and therapeutic products for companion animals, today announced it has signed a definitive agreement to acquire substantially all of the assets of Revo Squared LLC … Aug 18, 2023&ensp;&#0183;&ensp;Zomedica Corp. 69%) continued their recent rapid ascent on Tuesday. 2490 and closed that evening at $0.  By comparison, investing Aug 26, 2021&ensp;&#0183;&ensp;Today, social media is exploding with interest in ZOM stock as it shoots 20% higher.  Bloomberg TV is available … Oct 22, 2021&ensp;&#0183;&ensp;Speculative investors are crazy to be waiting to buy ZOM stock.  21. 1567, change for October 5. 02 statement, which is an earnings press release pertaining to results of operations and financial … May 19, 2022&ensp;&#0183;&ensp;About Zomedica Based in Ann Arbor, Michigan, Zomedica (NYSE American:ZOM) is a veterinary health company creating products for companion animals by focusing on the unmet needs of clinical Dec 15, 2022&ensp;&#0183;&ensp;Zomedica Corp. 07% for this period.  Q3'23. 14%) Today $0. 8 billion by 2024. de - … Jun 9, 2023&ensp;&#0183;&ensp;ANN ARBOR, MI / ACCESSWIRE / June 9, 2023 / Zomedica Corp.  The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. 192.  Upcoming EPS November 14th, 2023 After Hours.  Zomedica Corp.  Current Price: $0. : NYSE American Zomedica Corp. , Oct.  is a veterinary health company.  operates as a veterinary health company, which engages in the discovery, development, and commercialization of pharmaceuticals for the companion pet. 008 (4.  Larry Heaton, with 35+ years of medical device industry CA98980M1095.  The company is headquartered in Ann Arbor, Michigan and currently employs 85 full-time employees.  10: CI Transcript : Zomedica Corp. 91 on Feb.  NYSE: ZOM.  31, 2019. 96.  The animal health market is expected to reach $88.  10: CI Zomedica Corp.  As a highly shorted stock Mar 8, 2023&ensp;&#0183;&ensp;Zomedica Corp. 186 to a day high of $0. .  Though Aug 25, 2021&ensp;&#0183;&ensp;Some retail traders think Zomedica is headed for the $1 level in short order. 1548.  Zomedica inks Truforma distribution deal with Miller Feb 25, 2022&ensp;&#0183;&ensp;Gross margin was 73.  Zomedica is an animal health company focused on meeting the needs of clinical veterinarians in ways that promote both patient and practice health.  Jun 15, 2022&ensp;&#0183;&ensp;ANN ARBOR, MI / ACCESSWIRE / June 15, 2022 / Zomedica Corp.  Jan.  $189. 15.  Today’s Change.  Q3'22--$-0.  (NYSE American:ZOM) (&quot;Zomedica&quot; or the &quot;Company&quot;), a veterinary health company offering diagnostic and therapeutic products for companion animals, today announced that it had acquired substantially all the assets of Assisi Animal Health LLC (&quot;Assisi&quot;).  Find real-time SRNEQ - Sorrento Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.  Their disruptive tech cuts out the middle man in the multi billion dollar worldwide pet/vet sector. 007 / -3.  Zomedica Corp (US:ZOM) has 101 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC).  Zomedica ended the year with cash and cash equivalents on hand of $195 million.  Surprisingly Customizable penetration depth.  Zomedica revealed that there was a problem with the supplier responsible for producing test assays. 48K followers.  (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostic and therapeutic products for companion animals, today announced that it had acquired the Pulse Veterinary … Jul 5, 2023&ensp;&#0183;&ensp;Zomedica Corp.  Microad.  Find real-time ZOM - Zomedica Corp stock quotes, company profile, news and forecasts from CNN Business.  Aug 19, 2021&ensp;&#0183;&ensp;Zomedica reported sales of only $15,693 in the second quarter of 2021.  (NYSE American:ZOM) (&quot;Zomedica&quot; or the &quot;Company&quot;), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, today … Feb 17, 2022&ensp;&#0183;&ensp;As you may recall, early 2021 was a time when meme-stock traders were very powerful.  (NYSE American:ZOM) (&quot;Zomedica&quot; or the &quot;Company&quot;), a veterinary health company offering diagnostic and therapeutic products for companion animals, today announced a strategic Sep 8, 2021&ensp;&#0183;&ensp;Perhaps the news of a single sale was a letdown after all the pumping up of Zomedica on Reddit.  Aug 15, 2022&ensp;&#0183;&ensp;August 15, 2022 - 5:20 pm.  (NYSE American: ZOM) (Zomedica or the Company), a veterinary diagnostic company, today announced the pricing of its previously announced public offering of 33,333,334 common shares and warrants to purchase up to 16, Mar 16, 2021&ensp;&#0183;&ensp;Zomedica Announces First Commercial Sale of Its Truforma&#174; Platform.  Zomedica University News.  Sign Up.  Zomedica: Revolutionizing Veterinary Healthcare and Zomedica Corporation Reports 2022 Results: $18. 17% from a day low at $0.  Meanwhile, the company continues to lose Aug 4, 2023&ensp;&#0183;&ensp;Zomedica Announces Record Second Quarter 2023 Financial Results: Revenue up 43% to $6.  Investors cannot complain about a Feb 9, 2021&ensp;&#0183;&ensp;Source.  (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics May 11, 2023&ensp;&#0183;&ensp;/ Zomedica Corp.  Maximum value 0. 30 in January 2021, and then to a 52-week high of $2.  8.  These institutions hold a total of 99,314,931 shares. 5% in December, according to data provided by S&amp;P Global Market 1 day ago&ensp;&#0183;&ensp;Fundamentals.  Jun 6, 2021&ensp;&#0183;&ensp;Reports indicate the global companion animal market could hit $2.  Feb 26, 2021&ensp;&#0183;&ensp;Summary Year End 2020 Results.  But then, unfortunately, a multi-month slide commenced.  ORLANDO, FL / ACCESSWIRE / February 8, 2023 / RedChip Companies will air a new interview with Zomedica Corp.  The forecast for beginning of October 0.  52 Week Low Date 12/27/22.  Shares Out 979.  She is retiring to pursue personal interests.  Second, a big change in its C-suite.  GROUP LEADERSHIP.  (NYSE American:ZOM) (&quot;Zomedica&quot; or the &quot;Company&quot;), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, announced that it Apr 22, 2021&ensp;&#0183;&ensp;Zomedica (NYSEAMERICAN: ZOM) stock is taking off on Thursday despite a lack of news concerning the maker of medical devices for veterinarians.  Troubled businesses with low share prices were ideal short-squeeze targets for Reddit’s retail warriors.  8, Zomedica increased its bought deal offering. 9 Million Revenue; 72% Gross Margin &amp; $156 Million in Liquidity - Revenue up 361% from 2021 through combination of acquisitions and organic growth Market Capitalization. 90 a share at the time on 91. com - August 10 at 6:10 PM.  Share your ideas and get … 2 days ago&ensp;&#0183;&ensp;--- - 'ANN ARBOR, Mich. 04 million. 2049: Open: $0.  Mar 20, 2023&ensp;&#0183;&ensp;The bad news is that Zomedica hasn't been and still isn't profitable.  The following information was filed by Zomedica Pharmaceuticals Corp.  (SMP Oct 8, 2021&ensp;&#0183;&ensp;First, acquisition news.  Rooms Rankings Earnings Newsletters. 005 per share, and approximately $8.  fotostorm May 8, 2023&ensp;&#0183;&ensp;/ Zomedica Corp.  Jan 4, 2022&ensp;&#0183;&ensp;Zomedica ( ZOM 1. 2072: Prev Close: $0.  Annual Reports.  Aug 19, 2023&ensp;&#0183;&ensp;Stock Exchange Ticker Symbol Full Company Profile Financial Performance In 2022, Zomedica's revenue was $18.  The price has fallen in 7 of the last 10 days and is down by -13.  Sep 12, 2022&ensp;&#0183;&ensp;Zomedica is a developing company providing diverse veterinary supplies for large and small animals.  Jan 17, 2023&ensp;&#0183;&ensp;January 17, 2023 - 6:00 am. 02 percent on Wednesday, August 16, 2023, on approximately normal volume.  (NYSE American:ZOM) (&quot;Zomedica&quot; or the &quot;Company&quot;), a leading innovator in veterinary medicine offering diagnostic and therapeutic products for companion animals, announced today the launch of the revolutionary TRUVIEW TM digital microscopy platform, featuring the … Jun 9, 2023&ensp;&#0183;&ensp;Zomedica Announces Record First Quarter 2023 Financial Results: Revenue up 45% to $5. 17 with a 10% share of the pet diagnostic lab market.  Retirement 101 Why to Start Saving Now Types of Retirement Accounts Shares of Zomedica Pharmaceuticals (ZOM-1.  (NYSE American:ZOM) (&quot;Zomedica&quot; or &quot;Company, a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, reported consolidated financial results for the three and six month periods … Oct 1, 2021&ensp;&#0183;&ensp;October 1, 2021 - 6:01 am.  EXPECTED.  $0. 26. : Zomedica to Present at Sidoti Virtual Investor Conference August 16-17. , April 07, 2020 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp.  Aug 18, 2023&ensp;&#0183;&ensp;Zomedica (ZOM) Stock Forecast, Price &amp; News $0. 13 million.  (NYSE American:ZOM) (&quot;Zomedica&quot; or &quot;Company&quot;) on The RedChip Money Report&#174; on Bloomberg TV, this Saturday, February 11, at 7 p. 185 to $0.  Join the Conversation! Build your trading network; Follow your favorite assets Dec 31, 2022&ensp;&#0183;&ensp;Zomedica’s expanding product line-up addresses multi-billion-dollar market opportunities.  On August 11, the company reported its second-quarter earnings .  Its TRUFORMA biosensor platform is designed to assist practitioners in Oct 13, 2022&ensp;&#0183;&ensp;Zomedica Corp (ZOM) - DEVELOPMENT STAGE VETERINARY PHARMACEUTICAL COMPANY FOCUSES ON THE DISCOVERY OF DRUGS FOR THE PET ANIMALS.  View stock market news, stock market data and trading information.  (NYSE American:ZOM) ('Zomedica' or the 'Company'), a veterinary health company offering diagnostic and therapeutic Mar 24, 2021&ensp;&#0183;&ensp;Zomedica’s product launch will push its value higher. 32, on essentially no news at all.  At $1.  Fundamentals.  Assisi has … Jan 18, 2023&ensp;&#0183;&ensp;Zomedica stock rises ~15% on taking control of Truforma products via licensing deal.  It offers products for dogs and cats by focusing on the unmet needs of clinical veterinarians.  Mar 10, 2021&ensp;&#0183;&ensp;Bow wow! After debuting in mid-2017 and hitting an all-time-high of $2. 93 million, an increase of 358. 81%) Pre-Market Market Cap $181. 002 ( -1.  and Zomedica Inc.  Quarterly Reports &#169;2023 Zomedica Corp.  That's not much progress.  3rd Party Ad. 29 Sep 9, 2021&ensp;&#0183;&ensp;Perhaps the news of a single sale was a letdown after all the pumping up of Zomedica on Reddit.  ET on Monday. 01--N/A.  ANN ARBOR, MI / ACCESSWIRE / July 18, 2022 / Zomedica Corp. 32 million shares, the company raised around $173.  Home; Symbol; ZOM.  Zomedica Announces Record Second Quarter 2023 Financial Results: Revenue up 43% to $6.  Stock Info.  Price Target. 9 million. 335 52 … Zomedica Join Stocktwits for free stock discussions, prices, and market sentiment with millions of investors and traders. 8 million, loss in the year-ago period ended Dec. 6 billion by 2026.  as stated 20 years so expect them to … Feb 17, 2022&ensp;&#0183;&ensp;Shares of Zomedica Pharmaceuticals ( ZOM -3.  It creates products for companion animals by focusing on the unmet needs of clinical veterinarians.  Earnings Flash (ZOM) ZOMEDICA Posts Q2 Revenue $6M Aug.  The official website for the company is www.  Aside from growth stocks rebounding from the recent sector Aug 16, 2023&ensp;&#0183;&ensp;A Complete Shanghai Composite Index overview by Barron's. 63%.  Profile Analyst Ratings Chart Competitors Earnings Insider Trades Headlines Short Interest Social Media. 7 million, or $.  Zomedica recorded net loss and comprehensive loss for the year ended December 31, 2020 of approximately $16. 45 to $3.  News Releases. 190. 185 $0.  On Oct.  View real-time ZOM stock price and news, along with industry-best analysis. 00 52-Wk High $0. 03%) Mar 15, 2023&ensp;&#0183;&ensp;Zomedica Corp.  01, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp.  (NYSE American:ZOM) (&quot;Zomedica&quot; or &quot;Company&quot;), a veterinary health company offering point-of-care diagnostics and 1 day ago&ensp;&#0183;&ensp;Latest news about Zomedica Corp. 95M. C.  $6.  Committed to your success as a practitioner. com. , March 16, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp.  Source: didesign021 / Shutterstock.  (NYSE American:ZOM) (“Zomedica” or the “Company”), a leading innovator in veterinary medicine offering diagnostic and therapeutic products for companion animals, announced today the launch of the revolutionary TRUVIEW TM digital microscopy platform, featuring the … Apr 12, 2021&ensp;&#0183;&ensp;Thursday saw one of those meme stocks, Zomedica, surge by 7.  The veterinary health diagnostics stock closed last week at $0. 19 -0.  Zomedica also has granted to the underwriter a 30-day option to purchase up to 1,973,684 additional common shares Jun 9, 2023&ensp;&#0183;&ensp;ANN ARBOR, MI / ACCESSWIRE / June 9, 2023 / Zomedica Corp.  Zomedica (NYSEAMERICAN: ZOM) has had a string of victories in Jan 18, 2023&ensp;&#0183;&ensp;Zomedica Corp. S. , Q2 2023 Earnings Call, Aug 10, 2023 Aug.  ANN ARBOR, MI / ACCESSWIRE / December 15, 2022 / Zomedica Corp. 02% compared to … Aug 17, 2023&ensp;&#0183;&ensp;ZOM Zomedica Corp.  It offers products for dogs and cats.  Some retail traders think Zomedica is headed for the $1 level in short order.  IBD Partners. 1661, while minimum 0.  See … Aug 11, 2023&ensp;&#0183;&ensp;Zomedica Announces Record Second Quarter 2023 Financial Results: Revenue up 43% to $6. 72%), a veterinary health company focusing on point-of-care diagnostic products for pets, saw its shares drop 22.  Have a question? Apr 15, 2021&ensp;&#0183;&ensp;News. 0 Million; Strong 67% Gross Margin &amp; $142.  Additionally, Zomedica has an action plan to get the Truforma platform Aug 23, 2022&ensp;&#0183;&ensp;Zomedica Corp.  Right now it’s about growth &amp; as ZOM keeps growing they’re also a huge buyout target.  News.  NYSE | $USD | Market Close.  / Zomedica Corp. 7% higher as of 11:41 a.  Feb 8, 2021&ensp;&#0183;&ensp;Senseonics, Zomedica, and other ‘meme’ stocks surge, continuing the Reddit forum-driven rally that has propelled names likes GameStop and AMC.  (NYSE American:ZOM) (&quot;Zomedica&quot; or the &quot;Company&quot;), a veterinary health company offering diagnostic and therapeutic products for companion animals, today announced that in cooperation with Structured Monitoring Products, Inc. 00%. 01 (-5.  ZM-020 Patent granted for 20 year on Aug 31, 2021.  1, Zomedica announced plans to buy PulseVet for $70. 00 on no apparent specific news.  DOW 0. (NYSE American: ZOM) (Zomedica or the Company), a veterinary health company … 2 days ago&ensp;&#0183;&ensp;ZOM Zomedica Corp 132,835 $0.  0. m.   </span> </h3>

</div>

</div>

</div>

</div>

</div>

</div>

</div>

</div>

</div>

</div>

</div>

</div>

</div>

</body>
</html>
